ASTRAZENECA'S stock price has surged this morning following the announcement that blood clots from the drug are "extremely rare". -»
AstraZeneca share price jumps after blood clots from vaccine dismissed as ‘extremely rare’
Reviewed by Unknown
on
08 April
Rating:
No comments:
Post a Comment